济民健康
Search documents
9月4日晚间重要公告一览
Xi Niu Cai Jing· 2025-09-04 10:29
Group 1 - Huida Sanitary Ware plans to publicly transfer 100% equity and debt of Guangxi Xingaosheng, with debt amounts of 132 million and 138 million yuan as of June 30, 2025 [1] - Sainuo Medical received administrative regulatory measures from Tianjin Securities Regulatory Bureau due to inaccurate information disclosure in quarterly reports [2][3] - Jiangling Motors reported August vehicle sales of 30,003 units, a year-on-year increase of 8.92% [6] Group 2 - Jimin Health's controlling shareholder plans to reduce its stake by up to 3%, totaling 15.75 million shares [7] - Satellite Chemical announced routine maintenance of polyethylene and ethylene glycol facilities, expected to last 45 days [8] - Hubei Yihua's 200,000-ton caustic soda project has been successfully put into production [10] Group 3 - Shanghai Pharmaceuticals' Dihydroxypropyl Theophylline Injection has passed the consistency evaluation for generic drugs [13] - Ningbo Construction's subsidiaries won construction projects worth 1.117 billion yuan [16] - Wens Foodstuff reported August sales revenue of 4.825 billion yuan from live pigs, with a year-on-year decrease in revenue and price [28] Group 4 - Long-term Logistics announced the resignation of its deputy general manager due to personal reasons [44] - Huaming Equipment proposed a cash dividend of 2 yuan per 10 shares, totaling 179 million yuan [46] - Transsion Holdings plans to distribute a cash dividend of 0.8 yuan per share [49]
济民健康:控股股东双鸽集团拟减持不超3%公司股份
Xin Lang Cai Jing· 2025-09-04 10:17
Group 1 - The core point of the announcement is that Jimin Health's controlling shareholder, Shuangge Group, plans to reduce its stake in the company by up to 15.75 million shares, which represents no more than 3% of the total share capital [1]
股价大涨,济民健康股东拟减持不超3%公司股份
Bei Jing Shang Bao· 2025-09-04 09:42
Core Viewpoint - Jimin Health (603222) announced that its shareholder, Shuangge Group, plans to reduce its holdings by up to 15.75 million shares, representing no more than 3% of the company's total share capital due to its own funding needs [1] Company Summary - Shuangge Group intends to execute the share reduction through centralized bidding and block trading methods [1] - The stock price of Jimin Health has been on an upward trend recently, closing at 11.52 yuan per share on September 4, with a maximum increase of 64.34% from August 13 to September 4 [1]
济民健康(603222.SH):双鸽集团拟减持不超3%股份
Ge Long Hui A P P· 2025-09-04 09:32
Core Viewpoint - Jimin Health (603222.SH) announced that Shuangge Group plans to reduce its stake in the company by up to 15.75 million shares, representing no more than 3% of the total share capital, due to its own funding needs [1] Summary by Relevant Sections - **Share Reduction Plan** - Shuangge Group intends to reduce its holdings through centralized bidding and block trading methods [1] - The reduction will occur within three months after the announcement, starting fifteen trading days later [1] - The maximum shares to be reduced via centralized bidding will not exceed 1% of the total share capital, while block trading will not exceed 2% [1] - **Adjustment Clause** - The number of shares to be reduced and the reduction price will be adjusted accordingly if there are any events such as dividends, stock splits, capital reserve transfers, or rights issues during the reduction period [1]
济民健康:双鸽集团拟3个月减持不超3%
Xin Lang Cai Jing· 2025-09-04 09:32
济民健康公告,持股24.37%的控股股东双鸽集团因自身资金需求,计划在2025年9月29日至2025年12月 26日,通过集中竞价及大宗交易方式合计减持不超过1575.27万股,即不超过公司总股本的3%,其中集 中竞价不超过525.09万股,大宗交易不超过1050.18万股。 ...
济民健康(603222) - 济民健康管理股份有限公司股东减持股份计划公告
2025-09-04 09:31
证券代码:603222 证券简称:济民健康 公告编号:2025-044 济民健康管理股份有限公司 截至本减持计划公告之日,双鸽集团有限公司(以下简称"双鸽集团")持有 济民健康管理股份有限公司(以下简称"公司")股份 127,983,520 股,占公司 总股本的 24.37%,上述股份全部来源于公司首次公开发行前已持有的股份及上 市后资本公积转增股本取得的股份。 减持计划的主要内容 双鸽集团因自身资金需求,计划以集中竞价交易方式和大宗交易方式减持公 司合计不超过 15,752,718 股股份,即不超过公司总股本的 3%(若计划减持期间 有派息、送股、资本公积金转增股本、配股等除权除息事项,拟减持股份数量和 减持价格将相应进行调整),本次减持将在本减持计划公告之日起十五个交易日 后的 3 个月内进行,其中通过集中竞价交易方式减持股份不超过公司总股本的 1%, 通过大宗交易方式减持股份不超过公司总股本的 2%。 1 股东名称 双鸽集团 股东身份 控股股东、实控人及一致行动人 √是 □否 直接持股 5%以上股东 √是 □否 董事、监事和高级管理人员 □是 √否 其他:不适用 一、减持主体的基本情况 本公司董事会、全 ...
济民健康:实控人之一致行动人拟减持不超3%股份
Zheng Quan Shi Bao Wang· 2025-09-04 09:31
人民财讯9月4日电,济民健康(603222)9月4日晚间公告,公司控股股东、实控人之一致行动人双鸽集 团有限公司计划15个交易日后的3个月内,以集中竞价和大宗交易方式,减持公司股份合计不超过 1575.27万股,即不超过公司总股本的3%。 ...
16天9板济民健康:双鸽集团计划减持不超过3%公司股份
Mei Ri Jing Ji Xin Wen· 2025-09-04 09:29
(文章来源:每日经济新闻) 每经AI快讯,9月4日,济民健康(603222.SH)公告称,公司股东双鸽集团因自身资金需求,计划以集中 竞价交易和大宗交易方式减持公司股份合计不超过1575.27万股,即不超过公司总股本的3%。减持将在 公告之日起十五个交易日后的3个月内进行,其中通过集中竞价交易方式减持不超过1%,通过大宗交易 方式减持不超过2%。减持价格将根据市场情况和公司股价进行调整。双鸽集团承诺将严格遵守相关法 律法规和监管要求,及时履行信息披露义务。 ...
济民健康股东双鸽集团拟减持不超3%股份
Zhi Tong Cai Jing· 2025-09-04 09:26
济民健康(603222)(603222.SH)公告,公司股东双鸽集团计划以集中竞价交易方式和大宗交易方式减 持公司合计不超过1575.27万股股份,即不超过公司总股本的3%。 ...
济民健康(603222.SH)股东双鸽集团拟减持不超3%股份
智通财经网· 2025-09-04 09:23
智通财经APP讯,济民健康(603222.SH)公告,公司股东双鸽集团计划以集中竞价交易方式和大宗交易 方式减持公司合计不超过1575.27万股股份,即不超过公司总股本的3%。 ...